SCHEMBL22164263

SCHEMBL22164263

CC(C)(C)OC(=O)N1CCCC[C@H]1c1cc2nc(C3CCC3)cc(Cl)n2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE8B O95263 1/20 0.37
▸ TSHR P16473 5/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ LMNA P02545 3/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ ALDH1A1 P00352 6/20 0.37
▸ UCHL1 P09936 1/20 0.37
▸ USP30 Q70CQ3 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ CRHBP P24387 1/20 0.35
▸ CRHR2 Q13324 1/20 0.35
▸ HPGD P15428 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ EPHA2 P29317 1/20 0.35
▸ KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22175827 1.00 PDE8B (0.37) PDE8BTSHRMEN1KMT2ALMNA
SCHEMBL2737942 0.97 PDE8B (0.40) PDE8BTSHRMEN1KMT2ALMNA
SCHEMBL22164195 0.90 TSHR (0.40) PDE8BTSHRMEN1KMT2ALMNA
SCHEMBL221557 0.89 TSHR (0.38) PDE8BTSHRMEN1KMT2ALMNA
SCHEMBL2737908 0.87 HPGD (0.39) PDE8BTSHRMEN1KMT2ALMNA
SCHEMBL21279655 0.87 HPGD (0.39) PDE8BTSHRMEN1KMT2ALMNA
SCHEMBL22164278 0.84 TSHR (0.34) PDE8BTSHRMEN1KMT2ALMNA
SCHEMBL22175845 0.84 TSHR (0.34) PDE8BTSHRMEN1KMT2ALMNA
SCHEMBL30311179 0.84 TSHR (0.38) TSHRMEN1KMT2ALMNANPSR1
SCHEMBL22175836 0.83 MALT1 (0.42) TSHRMEN1KMT2ALMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230069963-A1 PYRAZOLO[1,5-A]PYRIMIDINE MACROCYCLIC COMPOUND TAISHO PHARMACEUTICAL CO., LTD. (JP) 2023-03-09 — — US disclosed
WO-2020138015-A1 PYRAZOLO[1,5-A]PYRIMIDINE MACROCYCLIC COMPOUND 大正製薬株式会社 2020-07-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230069963-A1 PYRAZOLO[1,5-A]PYRIMIDINE MACROCYCLIC COMPOUND ZC3HAV1, ZC3HAV1L, IL5 PDE8B 2269/4885TSHR 3277/4885MEN1 2874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback